Ex-J&J Doc Tells Okla. Judge Its Opioids Had Low Abuse Rate

Johnson & Johnson began its defense Thursday in Oklahoma's trailblazing trial seeking to hold it liable for the opioid crisis, calling a former medical director at its subsidiary Janssen Pharmaceuticals to testify...

Already a subscriber? Click here to view full article